Expanding the effector CD4 T-cell repertoire: the Th17 lineage

Current Opinion in Immunology

Volumn 18, Issue 3, 2006, Pages 349-356

  Harrington, Laurie E ^a   Mangan, Paul R ^a   Weaver, Casey T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; EFFECTOR CELL; HOST RESISTANCE; HUMAN; IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; INTERLEUKIN-17; MODELS, IMMUNOLOGICAL; TH1 CELLS; TH2 CELLS;

EID: 33646164439     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.03.017     Document Type: Review

References (53)

1. Leonard J.P., Waldburger K.E., and Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181 (1995) 381-386
2. Constantinescu C.S., Wysocka M., Hilliard B., Ventura E.S., Lavi E., Trinchieri G., and Rostami A. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol 161 (1998) 5097-5104
3. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187 (1998) 537-546
4. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
5. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., and Fathman C.G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156 (1996) 5-7
6. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., and Ramshaw I.A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157 (1996) 3223-3227
7. Kageyama Y., Koide Y., Yoshida A., Uchijima M., Arai T., Miyamoto S., Ozeki T., Hiyoshi M., Kushida K., and Inoue T. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 161 (1998) 1542-1548
8. Matthys P., Vermeire K., Mitera T., Heremans H., Huang S., and Billiau A. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 28 (1998) 2143-2151
9. + myeloid cells. J Immunol 163 (1999) 3503-3510
10. Bettelli E., Sullivan B., Szabo S.J., Sobel R.A., Glimcher L.H., and Kuchroo V.K. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 200 (2004) 79-87
11. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
12. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., Sedgwick J.D., and Cua D.J. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198 (2003) 1951-1957
13. Zhang G.X., Gran B., Yu S., Li J., Siglienti I., Chen X., Kamoun M., and Rostami A. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J Immunol 170 (2003) 2153-2160
14. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278 (2003) 1910-1914
15. Happel K.I., Zheng M., Young E., Quinton L.J., Lockhart E., Ramsay A.J., Shellito J.E., Schurr J.R., Bagby G.J., Nelson S., et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 170 (2003) 4432-4436
16. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
17. Nakae S., Nambu A., Sudo K., and Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171 (2003) 6173-6177
18. Lubberts E., Joosten L.A., Oppers B., van den Bersselaar L., Coenen-de Roo C.J., Kolls J.K., Schwarzenberger P., van de Loo F.A., and van den Berg W.B. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167 (2001) 1004-1013
19. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., and van den Berg W.B. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 (2004) 650-659
20. Koenders M.I., Lubberts E., Oppers-Walgreen B., van den Bersselaar L., Helsen M.M., Di Padova F.E., Boots A.M., Gram H., Joosten L.A., and van den Berg W.B. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 167 (2005) 141-149
21. Koenders M.I., Lubberts E., Oppers-Walgreen B., van den Bersselaar L., Helsen M.M., Kolls J.K., Joosten L.A., and van den Berg W.B. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1. Arthritis Rheum 52 (2005) 975-983
22. Bettelli E., and Kuchroo V.K. IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med 201 (2005) 169-171
23. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240. This report extended previous findings by this group [11,12], demonstrating differential gene expression by Th1 and Th17 cells and showing that Th17, but not Th1 cells, were potently pathogenic in an adoptive transfer model of EAE.
24. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., and Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 89 (1992) 6065-6069
25. + T cells from T cell receptor transgenic mice. J Exp Med 176 (1992) 1091-1098
26. Murphy K.M., and Reiner S.L. The lineage decisions of helper T cells. Nat Rev Immunol 2 (2002) 933-944
27. Berenson L.S., Ota N., and Murphy K.M. Issues in T-helper 1 development - resolved and unresolved. Immunol Rev 202 (2004) 157-174
28. + T cells. Immunity 16 (2002) 779-790
29. + T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 100 (2003) 15047-15052
30. Hibbert L., Pflanz S., De Waal Malefyt R., and Kastelein R.A. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23 (2003) 513-522
31. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., and Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000) 655-669
32. Mullen A.C., High F.A., Hutchins A.S., Lee H.W., Villarino A.V., Livingston D.M., Kung A.L., Cereb N., Yao T.P., Yang S.Y., et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292 (2001) 1907-1910
33. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., Hartley S.B., Menon S., Kastelein R., Bazan F., et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7 (1997) 571-581
34. + T cells: evidence for two distinct pathways for promoter activation. Eur J Immunol 29 (1999) 548-555
35. Zheng W., and Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89 (1997) 587-596
36. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., and Murphy K.M. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9 (1998) 745-755
37. Ouyang W., Lohning M., Gao Z., Assenmacher M., Ranganath S., Radbruch A., and Murphy K.M. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12 (2000) 27-37
38. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132. This study reported inhibitory effects of IFNγ and IL-4 on the development of IL-17-producing effectors. It also demonstrated that STAT1, T-bet, STAT4 and STAT6 were dispensable for development of IL-17-producing effectors in vitro, establishing an independent developmental lineage for Th17.
39. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141. This report provided independent confirmation of a distinct developmental lineage for Th17, extending key observations in vivo.
40. Lovett-Racke A.E., Rocchini A.E., Choy J., Northrop S.C., Hussain R.Z., Ratts R.B., Sikder D., and Racke M.K. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21 (2004) 719-731
41. Ota N., Brett T.J., Murphy T.L., Fremont D.H., and Murphy K.M. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat Immunol 5 (2004) 208-215
42. Chitnis T., Najafian N., Benou C., Salama A.D., Grusby M.J., Sayegh M.H., and Khoury S.J. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 108 (2001) 739-747
43. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., Pflanz S., Zhang R., Singh K.P., Vega F., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168 (2002) 5699-5708
44. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146
45. + T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J Immunol 175 (2005) 5666-5674
46. + T cells at priming and at recall: differential involvement of Stat4 and T-bet. J Immunol 174 (2005) 5950-5958
47. Dong C., Juedes A.E., Temann U.A., Shresta S., Allison J.P., Ruddle N.H., and Flavell R.A. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409 (2001) 97-101
48. Nurieva R.I., Duong J., Kishikawa H., Dianzani U., Rojo J.M., Ho I., Flavell R.A., and Dong C. Transcriptional regulation of th2 differentiation by inducible costimulator. Immunity 18 (2003) 801-811
49. Nurieva R.I., Treuting P., Duong J., Flavell R.A., and Dong C. Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest 111 (2003) 701-706
50. Amsen D., Blander J.M., Lee G.R., Tanigaki K., Honjo T., and Flavell R.A. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117 (2004) 515-526
51. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., Odden A.R., Shellito J.E., Bagby G.J., Nelson S., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202 (2005) 761-769
52. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton, RD, Wahl SM, Schoeb TR, Weaver CT: TGF-β induces development of the Th17 lineage. Nature 2006, in press. This study identified a central role for TGF-β to initiate commitment of naïve CD4 T cells to Th17 development. TGF-β was shown to induce IL-17 expression and to up-regulate the inducible chain of the IL-23 receptor (IL-23R) in the absence of IL-23, placing TGF-β upstream of IL-23 in Th17 development. This study also provided in vivo evidence that links TGF-β to Th17 development, demonstrating that mice deficient in TGF-β1 are deficient in Th17 cells and in circulating levels of IL-17.
53. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189. This study independently identified a role for TGF-β in Th17 development, showing that natural Tregs could be substituted for TGFβ. This study further showed that proinflammatory cytokines, particularly IL-6, augment IL-17 expression, linking effects of inflammation and natural Treg actions to cooperatively drive Th17 development.